| RS143663917 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing impairment, Inborn genetic diseases |
| RS1436643226 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS143664472 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1436663696 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1436664364 |
LAMP2
|
Health Risk |
Likely pathogenic |
Danon disease, Danon disease |
| RS1436671530 |
PROC
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Thrombophilia due to protein C deficiency |
| RS143667470 |
ERCC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group G |
| RS143667871 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1436692401 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Type 2 diabetes mellitus, Hyperinsulinemic hypoglycemia |
| RS143669458 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS143670820 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS143670942 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS143671341 |
DHX38
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS143671774 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS143671872 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS143671993 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly |
| RS143672318 |
RHBDF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Palmoplantar keratoderma-esophageal carcinoma syndrome, Inborn genetic diseases |
| RS1436725375 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1F |
| RS1436726865 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS1436734029 |
PRR12
|
Health Risk |
Likely pathogenic |
Neuroocular syndrome 1, Neuroocular syndrome 1 |
| RS143673459 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS143674856 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS143676075 |
PIGV
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 1, Inborn genetic diseases |
| RS143676414 |
TCF20
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Inborn genetic diseases |
| RS143676440 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1436764763 |
PCYT2
|
Health Risk |
Likely pathogenic |
Spastic paraplegia 82, autosomal recessive |
| RS1436765596 |
COQ7
|
Health Risk |
Pathogenic |
Primary coenzyme Q10 deficiency 8, Neuronopathy |
| RS143676607 |
CD109
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1436768029 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS143677057 |
MYF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant centronuclear myopathy, Autosomal dominant centronuclear myopathy |
| RS143677534 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1436775364 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
CFI-related disorder, CFI-related disorder |
| RS143677764 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1436778165 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS143678454 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, COL6A2-related disorder |
| RS143678523 |
TACC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143678590 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS143678893 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS143679158 |
AUTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism spectrum disorder due to AUTS2 deficiency, Autism spectrum disorder due to AUTS2 deficiency |
| RS1436794246 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS143679494 |
TICAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Herpes simplex encephalitis, susceptibility to |
| RS143679526 |
TTN
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1436796227 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS143679999 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1436804091 |
RSPH9
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS143680435 |
ABCG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Sitosterolemia 2 |
| RS143680532 |
DIS3L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Perlman syndrome, Perlman syndrome |
| RS143680577 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1436814142 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS143681974 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS143682303 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS143682914 |
MALT1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to MALT1 deficiency, Combined immunodeficiency due to MALT1 deficiency |
| RS143682977 |
EPB42
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 5, Hereditary spherocytosis type 5 |
| RS1436832739 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS143683496 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS1436840056 |
DSG1
|
Health Risk |
Pathogenic |
— |
| RS143684274 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS1436844070 |
CASQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 2, Cardiovascular phenotype |
| RS1436850036 |
GNE
|
Health Risk |
Pathogenic/Likely pathogenic |
GNE myopathy, Sialuria |
| RS143685061 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Cardiovascular phenotype |
| RS143685082 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS143685680 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1436857798 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Sessile serrated polyposis cancer syndrome, Sessile serrated polyposis cancer syndrome |
| RS1436866272 |
PMPCB
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 6, Multiple mitochondrial dysfunctions syndrome 6 |
| RS143687204 |
HARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1436874013 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS143687498 |
BMP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Microphthalmia with brain and digit anomalies, Orofacial cleft 11 |
| RS143689372 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1436895387 |
CCNO
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 29 |
| RS143690368 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1436928058 |
DCHS1
|
Health Risk |
Pathogenic |
— |
| RS1436928164 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1436930576 |
PLOD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bruck syndrome 2, Bruck syndrome 2 |
| RS1436932284 |
ODAD2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 23, Primary ciliary dyskinesia 23 |
| RS143693526 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS143693642 |
UGT2B17
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1436937190 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS143694260 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS143694311 |
FAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1436944837 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS1436956225 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1436960118 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS1436960562 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS143696500 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, LYST-related disorder |
| RS143696592 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS143697410 |
LHCGR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1436976326 |
TRMU
|
Health Risk |
Pathogenic/Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS143697828 |
SOX9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Camptomelic dysplasia |
| RS143697995 |
MRPL44
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency, Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency |
| RS143699328 |
HSD3B7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1436996181 |
SCUBE3
|
Health Risk |
Conflicting classifications of pathogenicity |
Abnormality of the dentition, Abnormal facial shape |
| RS143700608 |
CAMTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143702010 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
3-Methylglutaconic aciduria type 3, Optic atrophy 3 |
| RS1437021651 |
CRX
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy, Leber congenital amaurosis 7 |
| RS1437025228 |
ABHD12
|
Health Risk |
Likely pathogenic |
— |
| RS143702799 |
VCL
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1W, Cardiovascular phenotype |
| RS1437033667 |
MECP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Severe neonatal-onset encephalopathy with microcephaly |
| RS143703574 |
EXT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Exostoses, multiple |
| RS143704621 |
GAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS1437050890 |
NEU1
|
Health Risk |
Likely pathogenic |
— |